GigaGen, a biotech company, secures an $11.8M contract expansion with the US Department of Defense to develop synthetic human antibody treatments for botulinum neurotoxins.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 25, 2023.

For Thanksgiving, Infection Control Today® asked its Editorial Advisory Board what they're thankful for. From family to dreams coming true, they express gratitude for various aspects of life and work.

Marking the World Health Organization's World AMR Awareness Week, “Going Blue: Confronting the AMR Challenge,” urges health care providers and the public to educate, follow protocols, and ensure patient safety for antibiotic efficacy.

Mass General Brigham and Salem Hospital face a class action lawsuit over potential hepatitis and HIV exposure to hundreds of patients. The lawsuit alleges negligence and emotional distress, with the hospital claiming a minimal infection risk.

This interview with Cheron Rojo, BS, FCS, CHL, CIS, CER, CFER, CRCST, delves into a robust year-long study, starting in 2021, investigating the often-overlooked risks associated with insulated medical devices impacting both patients and medical staff.

Prepare for a healthcare "tripledemic" with Influenza, RSV, and COVID-19. Operating rooms face risks, but autonomous UV disinfection systems offer an effective solution to maintain sterility.

Read about a cluster randomized clinical trial that found that direct gloving without prior hand hygiene significantly improved infection prevention practice adherence among health care personnel.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 19, 2023.

A recent study in a Hong Kong hospital investigated a rhinovirus outbreak and its transmission via air dispersal. The research aimed to improve understanding of rhinovirus transmission in health care settings. This article summarizes the study's findings and implications for infection control.

Unlock the secrets to infection prevention in facelift surgery as renowned surgeons Dr. Konstantin Vasyukevic and Dr. Peter Lee share their expert insights and meticulous protocols in this informative interview.

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

The CDC recommends HCV testing for perinatally exposed infants and children to address the increasing incidence of hepatitis C among reproductive-age individuals, focusing on early detection and appropriate care.

Read a literature review that examines methods for laundering reusable surgical scrubs. Discover the importance of water temperature, disinfectants, and more in infection control.

At the Rockingham County Rehabilitation Center's Infection Control Fair, innovative and interactive approaches, including demonstrations, quizzes, and engaging activities, significantly promoted infection prevention education, making learning a fun and informative experience.

Recent CDC HICPAC revisions regarding SARS-CoV-2 control face criticism from the World Health Network and others due to alleged breaches in committee structure and erroneous infection control guidance, potentially impacting COVID-19 management and immunocompromised individuals in health care.

Kari A. Mergenhagen, PharmD, BCPS, BCIDP, discusses the potential of doxycycline in reducing C difficile infections among hospitalized patients with pneumonia. This interview delves into doxycycline's influence on patients with a prior C difficile history, demographic generalizability, exclusion criteria, and concerns regarding antibiotic resistance.

Health care-associated infections (HAIs) significantly impact patient outcomes, hospital expenses, and mortality rates in the United States. Hand hygiene stands as the most effective preventive method. While manual observation often produces biased results, Electronic Hand Hygiene Monitoring Systems (EHHCM) offer evolving methods for more accurate adherence assessment.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 5, 2023.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.

Staying Ahead with Company Updates and Product Innovations. This week's news is from Chicopee, GP Pro, US FDA, and Henry Schein.

Pharmaceutical company Qnovia partners with the University of Virginia (UVA) to create inhaled drugs for lung infections, bolstering their development pipeline with assets for pneumonia and biodefense-related pulmonary infections.

The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.

This combination vaccine candidate, with a safety profile consistent with Pfizer’s COVID-19 vaccine, will most likely be moving to a phase 3 trial in the coming months.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending October 29, 2023.